Cannae Holdings, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cannae Holdings, Inc. (NYSE: CNNE) on June 11, 2026, reporting events that occurred on June 10, 2026. The filing addresses significant changes in the Company's executive leadership, specifically within the finance function.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes
- Resignation of CFO: Bryan D. Coy resigned as Executive Vice President and Chief Financial Officer. The resignation is not due to any disagreement with the Company or the Board.
- Appointment of Interim CFO: Brett A. Correia was appointed as interim Chief Financial Officer. Mr. Correia, 39, previously served as the Company's Chief Accounting Officer since August 2019.
- Compensation Arrangements:
- Mr. Coy received accelerated vesting of 21,327 restricted shares.
- Mr. Coy is eligible for up to six months of base salary as transition payments, contingent on not finding new employment.
- Mr. Correia will receive a base salary of $300,000 and customary employee benefits. He has not entered into a formal employment agreement.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of new risks or contingencies. The primary contingency noted is the repayment obligation for Mr. Coy's transition payments should he secure new employment within the six-month period.
Key Facts for Investor Verification
- Verify the effective date of the CFO transition and the interim status of the new appointee.
- Confirm the total equity value associated with the 21,327 accelerated restricted shares for the departing CFO.
- Monitor future filings for the appointment of a permanent Chief Financial Officer.
- Note that the interim CFO, Brett A. Correia, has no formal employment agreement at this time.